Although this pathogenic process is shared between COVID-19 and the other beta-coronavirus infections, the massive increase of IL-10 levels in patients with severe forms of the illness is a clinical feature that uniquely distinguishes SARS-CoV-2 infections (211, 222). The gene discussed is IL10; the disease is COVID-19.